Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Julian Nikolaus Bucher"'
Autor:
Julian Nikolaus Bucher, Maximilian Koenig, Markus Bo Schoenberg, Alexander Crispin, Michael Thomas, Martin Kurt Angele, Daniela Eser-Valeri, Alexander Lutz Gerbes, Jens Werner, Markus Otto Guba
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224116 (2019)
Liver transplant (LT) programs in Germany increasingly face a multiethnic patient population. To date no outcome data for LT in patients with a history of migration is available for Germany. This complicates decision-making before wait-listing such p
Externí odkaz:
https://doaj.org/article/cc3ea4c4f58f448097273e57a73d19e5
Autor:
Markus Bo Schoenberg, Yongsheng Han, Xiaokang Li, Xinyu Li, Julian Nikolaus Bucher, Nikolaus Börner, Dominik Koch, Markus Otto Guba, Jens Werner, Alexandr V. Bazhin
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 2; Pages: 718
An operation in itself is a kind of trauma and may lead to immunosuppression followed by a bounce back. Not many studies exist that describe dynamics of the distribution of peripheral blood (PB) immune cells during the perioperative period. Consideri
Autor:
Yongsheng Han, Rainer Christoph Miksch, Julian Nikolaus Bucher, Jingcheng Hao, Markus B. Schoenberg, Nikolaus Börner, Alexandr V. Bazhin, Tobias S. Schiergens, Xinyu Li, Xiaokang Li, Markus Guba, Nicola Beger, Jens Werner, Dominik Koch
Publikováno v:
European Journal of Surgical Oncology. 47:2561-2570
Background For Hepatocellular carcinoma (HCC) surgery either through resection or transplantation often provides the only chance for cure. Since hepatocarcinogenesis and postsurgical prognosis is not only dependent on cirrhosis but also on immune act
Autor:
Dionysios Koliogiannis, Xinyu Li, Yongsheng Han, Julian Nikolaus Bucher, Jens Werner, Markus B. Schoenberg, Tong Zhu, Michaela Svihla, Alexandr V. Bazhin, Markus Guba, Xiaokang Li, J. Hao
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1103-1113
Background Liver transplantation and liver resection are curative options for early hepatocellular carcinoma (HCC). The outcome is in part depended on the immunological response to the malignancy. In this study, we aimed to identify immunological pro
Autor:
Joachim Andrassy, Jens Werner, Enrico N. De Toni, Max Seidensticker, Martin K. Angele, Markus Guba, Julian Nikolaus Bucher, Hubertus Johann Wolfgang Anger, Markus B. Schoenberg, Gerald Denk
Publikováno v:
Visc Med
Introduction: Current practice to only prioritize hepatocellular carcinoma (HCC) that fulfill the Milan criteria (INMC) is changing, since it causes the exclusion of patients who could benefit from liver transplantation. To select patients outside MC
Autor:
Enrico N. De Toni, Gerald Denk, Martin K. Angele, Max Seidensticker, Ursula Ehmer, Julian Nikolaus Bucher, Markus Guba, Hanno Nieß, Joachim Andrassy, Markus B. Schoenberg, Nikolaus Börner, Jens Werner, Andreas Umgelter, Dominik Koch
Publikováno v:
Transplant International. 34
Bridging therapy to prevent progression on the waiting list can result in a sustained complete response (sCR). In some patients, the liver transplantation (LT) risk might exceed those of tumor recurrence. We thus evaluated whether a watchful waiting
Autor:
Alexandr V. Bazhin, Enrico N. De Toni, Sebastian Hesse, Christoph Klein, Julian Nikolaus Bucher, Martin K. Angele, Markus Guba, Jens Werner, Markus B. Schoenberg, Nikolaus Börner, Max Seidensticker, Dominik Koch
Publikováno v:
Ann Transl Med
BACKGROUND: Due to organ shortage, liver transplantation (LT) in hepatocellular carcinoma (HCC) patients can only be offered subsidiary to other curative treatments, including liver resection (LR). We aimed at developing and validating a machine-lear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aaa49b8635c00430ea5729279c68607
https://europepmc.org/articles/PMC7210189/
https://europepmc.org/articles/PMC7210189/
Autor:
Jens Werner, Bernhard W. Renz, Michael Lauseker, Markus Guba, Moritz Drefs, Ulrich Wirth, Julian Nikolaus Bucher, Sebastian Wolf, Tobias S. Schiergens, Martin Ryll, Joachim Andrassy
Publikováno v:
Transplant Infectious Disease. 22
BACKGROUND Side effects of the immunosuppressive therapy after solid organ transplantation are well known. Recently, significant benefits were shown for mTOR-Is with respect to certain viral infections in comparison with CNIs. However, reported total
Autor:
Katharina Bruewer, Louisa Jutta Dietz, Michał Wysocki, Konrad Karcz, Johanna Hidding, Julian Nikolaus Bucher, Jens Werner, Nicole Trebesius, Markus B. Schoenberg
Background. Most robotic camera steering devices (RCSDs) require active steering by the surgeon and necessarily increase workload. Clinical experience shows that standard laparoscopic procedures can be performed safely as solo surgery aided by RCSDs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90b6481cf09f9cc5013d85cc41a4758
https://ruj.uj.edu.pl/xmlui/handle/item/266231
https://ruj.uj.edu.pl/xmlui/handle/item/266231
Autor:
Julian Nikolaus Bucher, Markus B. Schoenberg, Martin K. Angele, Hubertus Johann Wolfgang Anger, Alexandr V. Bazhin, Jens Werner, Michael Lauseker, Markus Guba, Tobias S. Schiergens, J. Hao, Michael Thomas, A. Vater, Markus Rentsch
Publikováno v:
Surgical Oncology. 27:663-673
OBJECTIVE To develop criteria for safe and oncologically satisfying liver resection in case of early hepatocellular carcinoma with a 5-year overall survival (OS) similar to liver transplantation. SUMMARY BACKGROUND DATA Liver resection (LR) and liver